Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response to CFTR-modulators in Intestinal Organoids of Patients With CF Having at Least One R334W Mutation

NCT04254705 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT04254705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04254705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response to CFTR-modulators in Intestinal Organoids of Patients With CF Having at Least One R334W Mutation
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Not applicable
Overall status
Withdrawn
Start date
March 1, 2020
Completion date
March 1, 2021
Enrollment
0 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis